PASG CIK: 1787297

Passage BIO, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
325
FY22:
197
FY23:
118
FY24:
78.8
FY25:
47.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
30.0
FY22:
46.5
FY23:
32.6
FY24:
23.6
FY25:
14.5
Total assets
Change from FY21 to FY25
millions USD
FY21:
355
FY22:
244
FY23:
151
FY24:
102
FY25:
62.3

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
29.5
FY22:
18.4
FY23:
16.3
FY24:
19.4
FY25:
23.1
(negative)
Change from FY21 to FY25
millions USD
FY21:
6.92
FY22:
23.8
FY23:
22.9
FY24:
21.8
FY25:
20.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
319
FY22:
201
FY23:
111
FY24:
61.3
FY25:
18.8
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
355
FY22:
244
FY23:
151
FY24:
102
FY25:
62.3

All amounts in millions USD Data source:SEC EDGAR